Northcape Wealth Management
BMY icon

Northcape Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Northcape Wealth Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$752K Buy
12,045
+147
+1% +$9.29K 0.2% 86
2026
Q2 		$686K Buy
11,898
+84
+0.7% +$4.82K 0.18% 90
2026
Q1 		$717K Buy
11,814
+11
+0.1% +$641 0.2% 85
2025
Q4 		$637K Sell
11,803
-501
-4% -$24.1K 0.18% 89
2025
Q3 		$555K Sell
12,304
-841
-6% -$39.3K 0.16% 97
2025
Q2 		$609K Sell
13,145
-85
-0.6% -$4.17K 0.19% 91
2025
Q1 		$807K Buy
13,230
+3,293
+33% +$192K 0.26% 75
2024
Q4 		$562K Buy
9,937
+3,860
+64% +$216K 0.18% 92
2024
Q3 		$314K Sell
6,077
-649
-10% -$30.4K 0.1% 112
2024
Q2 		$279K Buy
6,726
+254
+4% +$11.4K 0.1% 118
2024
Q1 		$351K Sell
6,472
-212
-3% -$10.8K 0.13% 102
2023
Q4 		$343K Buy
6,684
+402
+6% +$21.1K 0.12% 113
2023
Q3 		$365K Buy
6,282
+3,045
+94% +$187K 0.14% 110
2023
Q2 		$207K Buy
3,237
+220
+7% +$14.8K 0.07% 144
2023
Q1 		$209K Buy
+3,017
New +$213K 0.08% 145
2022
Q4 		– Sell
-5,567
Closed -$396K – 80
2022
Q3 		$396K Buy
5,567
+2,350
+73% +$170K 0.14% 103
2022
Q2 		$248K Sell
3,217
-2,080
-39% -$158K 0.09% 111
2022
Q1 		$387K Buy
5,297
+2,080
+65% +$140K 0.11% 113
2021
Q4 		$201K Buy
+3,217
New +$189K 0.07% 131

Other funds holding BMY

State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 26.62% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return

Northcape Wealth Management's BMY Position: Q3 2026 in Review

Northcape Wealth Management increased its Bristol-Myers Squibb (BMY) stake by 1.2% in Q3 2026, buying an estimated $9.29K and bringing the position to 12,045 shares worth $752K. The position accounts for 0.2% of the portfolio, ranked #86.

Northcape Wealth Management first reported a position in BMY in Q4 2021 and has held it in 19 quarters since. The position peaked at $807K in Q1 2025. 2,009 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Northcape Wealth Management held 12,045 shares of Bristol-Myers Squibb worth $752K as of Q3 2026.
  • Northcape Wealth Management bought 147 Bristol-Myers Squibb shares in Q3 2026, an estimated $9.29K.
  • Bristol-Myers Squibb made up 0.2% of Northcape Wealth Management's portfolio in Q3 2026, its #86 holding.
  • Northcape Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 19 quarters since.
  • Northcape Wealth Management's Bristol-Myers Squibb position peaked at $807K in Q1 2025.
  • 2,009 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Northcape Wealth Management's 13F filing for Q3 2026, filed 4 Nov 2026.